Press
Qvin in the press.
Coverage of Qvin, the Q-Pad and the science of menstrual blood, from TIME’s Best Inventions to The New Yorker and NPR.
Press inquiries
Writing about Qvin?
We are happy to help journalists and producers with interviews, background and images.
- InterviewsWith Sara Naseri, MD, CEO and Co-founder, and our scientific and clinical leadership.
- ImagesThe Q-Pad, our manufacturing, Qvin Labs and the founders, in high resolution.
- BackgroundThe science of menstrual blood, our FDA clearance and our published studies.
Coverage
Articles, interviews and awards.
Qvin Q-Pad: The 200 Best Inventions of 2024TIME names the Q-Pad one of the Best Inventions of 2024. The entry describes a menstrual pad with a removable strip that is mailed for clinical blood testing, with no clinic visit or needle.
The 50 greatest innovations of 2024Popular Science’s Best of What’s New 2024, the year’s top innovations. It includes the Q-Pad, which collects menstrual blood on a strip for lab testing, and notes its FDA clearance for A1c.
What Can We Learn from Menstrual Blood?A long-form feature on the science of menstrual blood and why research on it has lagged. It describes the Q-Pad, its dried blood strip and A1c test, and Sara’s early work with Stanford’s Paul Blumenthal.
Long overlooked, menstrual blood is a treasure trove for scienceAn All Things Considered interview with a journalist reporting on the new science of period blood. She describes visiting Qvin, trying the Q-Pad, and how the lab measures A1c from the dried strip.
The firms that want to test menstrual bloodA BBC business story on the startups working to test menstrual blood, and the funding hurdles they face. It profiles Sara and Qvin’s research on markers such as blood sugar and cholesterol.
Dr. Jennifer Ashton on GMA3A GMA3 segment in which ABC News Chief Medical Correspondent Dr. Jennifer Ashton discusses the newly FDA-cleared Q-Pad. She calls the potential impact on women's health worldwide significant.
Sohn HK 2022 supports Qvin researchA Bloomberg Markets Asia interview with Sara Naseri, co-founder and CEO of Qvin, around the Sohn Hong Kong 2022 investment conference. Proceeds from the event support research giving women from all walks of life equal access to blood testing.
We Shouldn’t Dismiss The Diagnostic Power Of Menstrual Blood. Period.An opinion piece arguing that menstrual blood deserves serious attention as a diagnostic sample. It cites the FDA clearance of the Q-Pad and A1c Test, and the pad’s earlier research use for HPV.- FemTech Startups Want To Unlock The Potential Of Menstrual BloodA column on femtech startups exploring menstrual blood as a diagnostic resource. It cites Stanford research on menstrual A1c and inflammation markers, and names Qvin as the company building the pad.
This ingenious new period pad can screen you for deadly diseasesA design feature on the Q-Pad and the long development process behind it. It explains how the pad’s removable strip is mailed for lab testing, and traces Sara’s path from medical school to founding Qvin.
Dr. Sara Naseri: Menstrual blood as a diagnostic toolAn Axios podcast episode on innovation in women’s health, with Sara Naseri as guest. She explains why Qvin treats menstrual blood as a diagnostic sample and discusses the FDA clearance of the Q-Pad.
The race to understand, and profit from, period bloodAn in-depth feature on the emerging science of menstrual blood and its long neglect in medicine. It opens in Qvin’s lab, describing the Q-Pad’s A1c test and plans for HPV and fertility hormone tests.
What can period blood reveal about a person's health?A Science News feature on what period blood can reveal about health. It follows Sara Naseri's research from medical school onward and describes the Q-Pad, the first FDA-cleared health test based on period blood, which measures A1c.
Could Collecting Period Blood Via A Menstrual Pad Offer An Alternative To Uncomfortable Pap Smears?A health feature on whether period blood could one day replace some invasive screening, such as Pap tests. It walks through how the Q-Pad kit is used at home and how Sara’s research on menstrual blood began.
The truth about your periodAn On Point radio episode on what periods and menstrual fluid can reveal about health. Sara Naseri joins as a featured guest, representing Qvin and its diagnostic menstrual pad.
Q-Pad Test System to Measure A1CA Diagnostic Tests review in the journal American Family Physician on the Q-Pad Test System for measuring A1c from menstrual blood. Physicians from Penn State Health assess its accuracy, benefits, limitations and cost for clinicians considering the at-home test.
Qvin Launches and Receives FDA Clearance for Menstrual Blood Testing Q-PadWWD covers the launch of Qvin and the FDA clearance of the Q-Pad for A1c testing from menstrual blood. It describes the kit of two cotton pads with removable strips and quotes Sara Naseri on women with chronic illness welcoming fewer lab visits.
Using Menstrual Pads for Blood TestsA short TechCrunch video on Qvin, then a Y Combinator company called Qurasense. It presents the diagnostic menstrual pad as a natural, needle-free alternative to a blood draw for monitoring health.
Sara Naseri, CEO & Co-Founder, Qvin | MAKERS ProfileA short MAKERS video profile of Sara Naseri, CEO and co-founder of Qvin. It introduces her as a founder whose company is built around testing menstrual blood for health information.
Pap smears, be gone? Using menstrual blood to detect HPVStanford Medicine’s story on a published study using menstrual blood to screen for HPV. It describes the Q-Pad’s cotton design and removable strip, and Sara’s work to make it widely available.
I Tried a Diagnostic Menstrual Pad to Learn More About My Health: Here's How It WentA first-person review in which the writer tries the Q-Pad A1c kit after its January 2024 FDA clearance. Sara Naseri explains the science behind menstrual blood testing and the biomarkers Qvin is researching beyond A1c.
What Can Menstrual Blood Reveal about Health and Disease?A science feature on what menstrual blood may reveal about health and disease. It profiles Sara, her Stanford studies matching menstrual and circulating blood markers, and Qvin’s plans.
Sara Naseri: Unleashing the Potential of Menstrual BloodA Yale Scientific profile of Sara Naseri, tracing her path from medical student to co-founder of Qvin. It explains how the Q-Pad collects menstrual blood for FDA-cleared A1c testing and highlights research on HPV and the TIME Best Inventions 2024 recognition.- Femtech InsiderQvin's Menstrual Blood Health Testing Q-Pad Is Now FSA/HSA EligibleFemtech Insider reports that the Q-Pad A1c Test can now be paid for with FSA and HSA funds. The article recaps how the Q-Pad collects menstrual blood on a removable strip for lab analysis after its January 2024 FDA clearance.
Going with the flow: how menstrual blood could revolutionise healthcareA feature on menstrual blood as a source of health data, and the gender gap in medical research. It profiles Sara and explains how the Q-Pad collects a sample that a lab analyzes for A1c.
Period blood could help diagnose diabetes and other illnessesA Science News Explores story for younger readers on how period blood could help diagnose diabetes and other illnesses. It features Sara Naseri's research and explains how the Q-Pad, the first FDA-cleared period blood health test, measures A1c.
Taboo or Liquid Gold? Period Blood Is the Key to Managing Women's HealthA syndicated Radio Health Journal segment, hosted by Greg Johnson, on menstrual blood as a source of health information. Sara Naseri, co-founder and CEO of Qvin, is the featured guest and explains how menstrual blood can help women manage their health.
Menstrual Blood Diagnostic Testing: Q&A With Dr. Sara NaseriA Q&A with Sara Naseri on the LOLA blog, for Women’s History Month. It covers her research background, the Q-Pad, and the markers Qvin has studied in menstrual blood, including A1c and HPV.- News-MedicalDisrupting the Flow: Dr. Naseri's Revolutionary Approach to Empowering Women's HealthAn interview with Sara Naseri for International Women’s Day. She discusses what led her to found Qvin, the Q-Pad technology, and the case for menstrual blood as a source of lab data.
Transforming monthly periods to diagnostic potential: An interview with Dr. Sara NaseriAn interview by design consultancy Smart Design with Sara Naseri on turning monthly periods into diagnostic data. Sara discusses the design iterations behind the Q-Pad, collection at home, cervical cancer screening research and bringing more women into clinical trials.- Femtech InsiderQvin’s Q-Pad Makes History with First FDA Approval for Menstrual Blood Health TestingA news report on the FDA clearance of the Q-Pad and A1c Test for over-the-counter use. It explains that the strip is analyzed in a CLIA-certified lab, and quotes co-founders Sara and Søren.
Qvin menstrual pad blood test bags FDA clearanceMedical Device Network reports the FDA clearance of the Q-Pad, a menstrual pad with a removable strip that collects blood for A1c testing. Sara Naseri calls it the first FDA-cleared menstrual blood health test, built to make routine testing easier for women with diabetes.
FDA Clears Qvin Test that Uses Menstrual BloodClinical Lab Products reports that the FDA has cleared the Q-Pad and its A1c Test, which use menstrual blood instead of a venous blood draw. Sara Naseri is quoted calling it the first FDA-cleared menstrual blood health test.
Qvin's world-first diagnostic menstrual pad gets FDA clearanceFutureFemHealth, a newsletter on women's health innovation, reports the FDA clearance of the Q-Pad, with A1c monitoring as its first indication. It explains the tear-off collection strip and results in the app, and quotes Sara Naseri on menstrual blood as an accessible source of health data.
Hun samler menstruationsblod i bøtter, vil bruge metode, som ingen har brugt førA Danish TV 2 news feature on Danish women researching menstrual blood as a diagnostic sample. It profiles Sara Naseri, ten years into the field with Qvin, just after the Q-Pad received FDA clearance in the US.
Harnessing the Power of Periods for A1C TestingA diaTribe explainer for people living with diabetes, published days after the FDA clearance of the Q-Pad A1c Test. It explains how the Q-Pad collects menstrual blood for A1c monitoring in the lab and what the clearance means for patients.
Start-Ups wollen Gesundheitsdaten aus Menstruationsblut gewinnenA German-language science article from Austria's futurezone on start-ups extracting health data from menstrual blood. It features the Q-Pad, then in development for markers such as thyroid levels and HPV, and Sara Naseri's finding that menstrual blood was barely studied.
Le sang menstruel pourrait bientôt être utilisé pour faire avancer la rechercheA French-language Slate article on how menstrual blood could soon help advance medical research and diagnostics. Qvin is among the start-ups it cites working to turn period blood into a source of health information.
Female Disruptors: Sara Naseri of Qvin On The Three Things You Need To Shake Up Your IndustryA Q&A with Sara Naseri in Authority Magazine’s series on women disrupting their industries. She describes her medical background, how Qvin began, and why menstrual blood is an overlooked sample.
Menstrual blood holds the key to better diagnosticsA feature on menstrual blood as a frontier for preventive diagnostics. It recounts Sara and Stanford’s Paul Blumenthal comparing menstrual and venous blood markers, and the doubts they met.
Menstrual Blood Shows Promise as HPV Screening ToolA health news story on a study testing self-collected menstrual blood to screen for HPV. It names Sara as study lead and interviews Paul Blumenthal on how Q-Pad samples compared.
30-årige Sara har opfundet et menstruationsbind, der kan opdage kræft. Lederen af laboratoriet syntes, det var klamtA Danish Zetland story on Sara Naseri and the skepticism she met while building a diagnostic menstrual pad. It uses her path to examine how a male-dominated investor world shapes which ideas get funded.
Turning Period Blood Into Diagnostic DataAn episode of the Ctrl.Alt.Thrive podcast, hosted by Navneet Kaur, on how Qvin turns menstrual blood into clinical-grade diagnostic data. It covers the first FDA-cleared diagnostic menstrual pad and what a monthly sample opens up for women's health.
S1E9: Power in Your Period: How Qvin Is Using Menstrual Blood to Revolutionize DiagnosticsAn episode of the RedefineHER podcast, hosted by Brenda Armstrong, with Sara Naseri, CEO and co-founder of Qvin. Sara talks about menstrual blood for early diagnostics, from FDA clearance to global studies and research with Stanford.
FemTechAn episode of the Century Lives podcast on women closing the women's health gap, which travels to Silicon Valley to meet Sara Naseri. It traces how her question about what monthly bleeding could reveal led to Qvin and the Q-Pad.
From Taboo to Treatment: How 400 Proteins in Menstrual Blood May Be the Future of Preventative CareAn episode of the Femtech Health Podcast in which Sara Naseri tells the origin story of the Q-Pad. She covers ten years from medical school to FDA clearance, the data gap in women's health and the untapped potential of menstrual blood.
Revolutionizing Women's Health: Dr. Sara Naseri's Mission to Unlock the Power of Menstrual BloodAn episode of the Badass Women in Business podcast on Sara Naseri's mission to unlock the diagnostic power of menstrual blood. Sara shares the path from medical school to launching the first FDA-cleared menstrual pad for A1c monitoring.
Your Diabestie learns about how your period can predict your Hemoglobin A1C | Qvin & Dr. Sara NaseriAn episode of Mila Clarke's Your Diabestie podcast on how a period can help track A1c. Sara Naseri explains how Qvin turns a menstrual pad into a diagnostic tool and what that means for access to testing in women's health.
Revolutionizing A1C and Biomarker Testing with the Q-PadAn episode of the Diabetech podcast that takes a close look at the Q-Pad with Qvin's founder. It covers the FDA-cleared A1c test and the other biomarkers menstrual blood could reveal, from thyroid health to fertility.
Unboxed Series: Beyond the Blood Test: Qvin's Menstrual Pad for Seamless A1C TrackingA DiabetesSisters video webinar, hosted by Sara Naseri, on using the Q-Pad for A1c monitoring at home. Four women living with diabetes share their experience with the first FDA-cleared menstrual pad for A1c testing.
How Qvin's Q-Pad Could Transform Women's Health Through Menstrual Blood TestingA livestreamed interview on the Health and Pharma channel with Sara Naseri, CEO and co-founder of Qvin. It explores the Q-Pad as the first FDA-cleared menstrual blood test and how it helps women keep track of their health.
Dr Brooke Show #417 Utilizing Menstrual Blood For Common Lab Tests With Dr. Sara Naseri, MDAn episode of the Dr. Brooke Show on affordable A1c testing at home using menstrual blood. Sara Naseri explains how the Qvin test works and where research on menstrual blood could go next, including other hormones.
Ep. 131: Reimagining Preventative Medicine For Women With DiabetesAn episode of The L Podcast on making A1c testing easier for people with diabetes who menstruate. Sara Naseri discusses the science behind Qvin, health equity and how listeners can take part in women's health research.
This period pad measures A1C: All about Qvin with CEO Dr. Sara NaseriAn interview on Stacey Simms' Diabetes Connections podcast about Qvin's FDA-cleared approach to A1c testing. Sara Naseri explains how the Q-Pad collects menstrual blood for lab testing and why that matters for people with diabetes.
How to Use Your Menstrual FlowAn episode of the Black Women's Health podcast asking why menstrual flow is not used for diagnosis the way blood, saliva and urine are. Sara Naseri joins to discuss what menstrual blood can already tell us, and what comes next.
Dr. Sara Naseri: Biomarkers in Menstrual Blood, the Women's Health Movement & Breaking Stigma in ScienceAn episode of the MOTHER podcast, hosted by Karina Vazirova, with Sara Naseri, co-founder and CEO of Qvin. Sara talks about biomarkers in menstrual blood, the Q-Pad's FDA clearance, cervical cancer screening research and the stigma around menstrual blood in science.
How Menstrual Blood Is Being Transformed Into a Diagnostic ToolAn episode of Clinical Lab Chat, the Clinical Lab Products podcast, in which host Chris Wolski interviews Sara Naseri. Sara covers the origin of the Q-Pad, breaking taboos around menstruation, better access to care and what comes next for Qvin.
Sara Naseri | The 2022 MAKERS ConferenceSara Naseri on stage at the 2022 MAKERS Conference, streamed on the MAKERS channel. MAKERS billed the 15-minute talk as Qvin revealing a game-changing innovation in women's health.